Significant improvement of ocular clinical pictures of iris metastasis from small-cell lung cancer after systemic chemotherapy

Li-Ying Huang; Ning-Yi Hsia; Chun-Ting Lai; Peng-Tai Tien; Chun-Ju Lin; Jane-Ming Lin; Yi-Yu Tsai; Wen-Lu Chen

doi:10.4103/tjo.tjo_59_20

Significant improvement of ocular clinical pictures of iris metastasis from small-cell lung cancer after systemic chemotherapy

Taiwan J Ophthalmol. 2020 Nov 6;11(4):402-404. doi: 10.4103/tjo.tjo_59_20. eCollection 2021 Oct-Dec.

Authors

Li-Ying Huang¹, Ning-Yi Hsia¹, Chun-Ting Lai¹, Peng-Tai Tien¹, Chun-Ju Lin^{1

2

3}, Jane-Ming Lin¹, Yi-Yu Tsai^{1

2}, Wen-Lu Chen¹

Affiliations

¹ Department of Ophthalmology, China Medical University Hospital, China Medical University, Taichung City, Taiwan.
² School of Medicine, College of Medicine, China Medical University, Taichung City, Taiwan.
³ Department of Optometry, Asia University, Taichung City, Taiwan.

Abstract

The uveal tract is the most common ophthalmic site of ocular metastasis from systemic tumors due to the luxurious blood flow within the choroidal tissue. However, iris metastasis from systemic cancer is uncommon, accounting for only 8% of cases of uveal metastasis. There are several methods for the treatment of iris tumor. Here, we reported a case of iris metastasis from small-cell lung cancer. The tumor shrunk after systemic treatment for lung cancer and showed no recurrence after a 4-month follow-up.

Keywords: Iris metastasis; chemotherapy; lung cancer.

Publication types

Case Reports